Everence Capital Management Inc Bio Rad Laboratories, Inc. Transaction History

Everence Capital Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 03, 2024	BUY	$268.26 - $339.48 $126,082 - $159,555	470 Added 29.01%	2,090 $564,000
Q3 2023 Oct 16, 2023	BUY	$350.25 - $422.63 $315,225 - $380,367	900 Added 125.0%	1,620 $581,000
Q4 2022 Jan 31, 2023	BUY	$351.71 - $456.01 $38,688 - $50,161	110 Added 18.03%	720 $303,000
Q3 2022 Oct 07, 2022	SELL	$412.59 - $563.26 $28,881 - $39,428	-70 Reduced 10.29%	610 $254,000
Q2 2022 Jul 26, 2022	BUY	$463.67 - $597.16 $315,295 - $406,068	680 New	680 $337,000
Q1 2022 Apr 11, 2022	SELL	$524.57 - $735.42 $304,250 - $426,543	-580 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$708.84 - $794.68 $297,712 - $333,765	-420 Reduced 42.0%	580 $438,000
Q4 2020 Feb 01, 2021	BUY	$510.68 - $643.45 $255,340 - $321,725	500 Added 100.0%	1,000 $583,000
Q3 2020 Feb 01, 2021	BUY	$454.43 - $535.6 $227,215 - $267,800	500 New	500 $258,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.19B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Everence Capital Management Inc with notifications on news.